Arkolith/Insider Trading/EMMA/Form 4

Niihara Yutaka

Chairman and CEO, Director, 10% OwnerEmmaus Life Sciences, Inc. (EMMA) · full profile →Form 4 · filed Nov 3, 2022
Net Buying
Open-Market Buys
$12K
Open-Market Sells
$0
Net Open-Market Flow
$12K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Nov 2, 2022Buy(P)15K$0.43$6K12.0M
Nov 1, 2022Buy(P)5K$0.43$2K12.0M
Oct 31, 2022Buy(P)8K$0.45$3K12.0M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-22-055471) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML